NVIDIA announced that the new AI Center at Mahidol University (MU) in Thailand has adopted NVIDIA DGX A100 systems and the NVIDIA Clara platform for healthcare to power drug discovery research, with a focus on genomics, proteomics, pathology and radiology.
Housed at the university’s Salaya campus, the center will enable multi-disciplinary research collaboration and allow researchers to solve the world’s most challenging problems on the NVIDIA-based platform using both hardware and software.
It will initially support projects from the Cluster of Excellence in AI-Based Medical Diagnosis, the Integrative Computational BioScience Center and the Artificial Intelligence-Integrated Drug Discovery Platform, from the Faculty of Information and Communication Technology, Faculty of Medicine Siriraj Hospital and Faculty of Pharmacy, respectively.
"At Mahidol University, we realize that Artificial intelligence will have a hug impact to our missions of Higher Education. Artificial intelligence has acted as the main driver of emerging technologies like big data, robotics and IoT, and it will continue to act as a technological innovator for the foreseeable future. This is undoubtedly that we must have our advanced AI center within Mahidol University to facilitate and strengthen our future roles as a leading Thai university in Academia and to be a World Class University” said Prof. Banchong Mahiasavariya, President of Mahidol University.